Senior VP of Regulatory
Lynn Gold has over twenty-five years of leadership experience in the pharmaceutical industry. Prior to joining Impel, Lynn was VP of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services providing strategic direction and scientific development consulting to the pharmaceutical industry.
Lynn began her career with Pharmacia in parenteral nutrition product development, which through merger’s became Pharmacia and Upjohn and then Fresenius Kabi. Lynn then joined Warner Chilcott with responsibilities for formulation development, clinical supply, stability, marketed product support, and regulatory support. In 2004, she moved to Sonus Pharmaceuticals as VP Research and Process Development focusing on oncology product development via the 505(b)(2) regulatory pathway. Lynn has a Bachelor’s degree in Chemistry from SUNY at Buffalo and a Ph.D. in Physical Organic Chemistry from University of Rochester.